New possibilities of neuroprotection in the treatment of ischemic stroke
Controlled study in people · 2008
- What was studied
- 62 acute hemispheric ischemic-stroke patients; 32 Cortexin and 30 placebo; treatment started within six hours
- Main finding
- The double-blind multicenter report described improvement in neurological and functional scales compared with placebo.
Reported findings and study design
62 acute-stroke patients in a double-blind placebo comparison: Cortexin 32 versus placebo 30. Cortexin 20 mg/day IM for ten days, beginning within six hours; assessments through day 28.
Population or model 62 acute hemispheric ischemic-stroke patients; 32 Cortexin and 30 placebo; treatment started within six hours
Dose, route and schedule
Cortexin: 20 mg intramuscularly daily for 10 days, beginning within the first six hours of stroke onset, alongside stroke care.
Protocol source ↗ · Indexed publication abstract
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Neurological and functional scales | Authors report favorable outcomes | NIHSS, mRS and Barthel measured; numerical scores and effect sizes absent from the abstract |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Small trial; random sequence generation is not established by the abstract.
- No numerical treatment effect or adequate assessment of uncommon harms is available in the abstract.
Source details
Indexed citation and abstract reviewed via Europe PMC / PubMed; full methods and risk of bias not comprehensively appraised.
Abstract reviewed
Sources checked
Citation
Skoromets AA, Stakhovskaia LV, Belkin AA, Shekhovtsova KV, Kerbikov OB, Burenchev DV, Gavrilova OV, Skvortsova VI. New possibilities of neuroprotection in the treatment of ischemic stroke Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PMID 19431244